Dimethyl Fumarate: A Review in Relapsing-Remitting MS-Reference-Cited by-同舟云学术

Dimethyl Fumarate: A Review in Relapsing-Remitting MS

Published:2019-11-29 Issue:18 Volume:79 Page:1965-1976
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Blair Hannah A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-019-01229-3.pdf

Reference96 articles.

1. Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43.

2. Montalban X, Gold R, Thompson AJ, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler. 2018;24(2):96–120.

3. National Multiple Sclerosis Society. MS. 2019. http://www.nationalmssociety.org. Accessed 13 Nov 2019.

4. Linker RA, Chan A. Navigating choice in multiple sclerosis management. Neurol Res Pract. 2019. https://doi.org/10.1186/s42466-019-0005-5.

5. Costello K, Kalb R. The use of disease-modifying therapies in multiple sclerosis: principles and current evidence. 2014. http://www.nationalmssociety.org. Accessed 13 Nov 2019.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis;Cell Metabolism;2024-08

2. Dimethyl fumarate ameliorates chronic stress-induced anxiety-like behaviors by decreasing neuroinflammation and neuronal activity in the amygdala;International Immunopharmacology;2024-08

3. Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders;Molecular Neurobiology;2024-07-23

4. Selective activation of cellular stress response pathways by fumaric acid esters;FEBS Open Bio;2024-05-24

5. Identification of key neuronal mechanisms triggered by dimethyl fumarate in SH-SY5Y human neuroblastoma cells through a metabolomic approach;Archives of Toxicology;2024-02-18